Leave it to Alex Rodriguez to keep Alex Rodriguez relevant. While the New York Yankees failed to make the playoffs, Rodriguez is still making headlines in October. Â He is currently appealing his 211 game suspension handed down this year for being connected to the Biogenesis clinic which provided him banned substances. Â As if that was not shocking enough, he has now filed a lawsuit against Commissioner Bud Selig and Major League Baseball claiming they are on a ‘witch hunt’ to bring him down.
In the lawsuit, Rodriguez claims that MLB bought Biogenesis owner Anthony Bosch’s cooperation. Â The lawsuit goes on to say that MLB paid for private security for Bosch as well as all of his legal bill. Â The Yankees are not named in the lawsuit as defendants. Â However, Rodriguez did believe that the Yankees wanted Rodriguez to be injured so they would not have to pay the rest of his massive contract; instead insurance would pay most of it. Â His legal team is planning another suit against the Yankees team doctor, this one for malpractice. Â This guy really thinks he is bigger than baseball. Â You could have been one of the best, but instead you are a disgrace to professional athletes. Â To read all of the court documents, click here.
[UPDATE] MLB has responded to Rodriguez’s claims and basically said what we were all thinking, “nothing more than a desperate attempt to circumvent the Collective Bargaining Agreement.” Below is the rest of their statement:While we vehemently deny the allegations in the complaint, none of those allegations is relevant to the real issue: whether Mr. Rodriguez violated the Joint Drug Prevention and Treatment Program by using and possessing numerous forms of prohibited performance-enhancing substances, including Testosterone and human Growth Hormone, over the course of multiple years and whether he violated the Basic Agreement by attempting to cover-up his violations of the Program by engaging in a course of conduct intended to obstruct and frustrate the Office of the Commissioner’s investigation.
